Robins Kaplan Partners Gary Wilson, Tara Sutton and Munir Meghjee appointed to Abilify MDL Litigation Leadership
pharamaceutical | December 29, 2016
Abilify, also known as aripiprazole, is usually prescribed to treat a variety of disorders including schizophrenia, irritability, agitation, depression and mania. Sometimes, it is prescribed for patients along with an anti-depressant (called a serotonin reuptake inhibitor) for more severe depressive disorders. Abilify was developed and manufactured by Otsuka Pharmaceutical Co., headquartered in Japan, and Bristol-Myers Squibb, headquartered in New York.